Drug Profile
NOX 100
Alternative Names: Norathiol; NOX-100Latest Information Update: 03 Oct 2019
Price :
$50
*
At a glance
- Originator Medinox
- Developer Medinox; Orient Europharma
- Class Free radicals; Hexanols; Small molecules; Thiocarbamates; Vascular disorder therapies
- Mechanism of Action Nitric oxide inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Intradialytic hypotension; Septic shock
- Discontinued Acute lung injury; Adult respiratory distress syndrome; Transplant rejection
Most Recent Events
- 03 Oct 2019 Chemical structure information added
- 01 Jul 2015 Medinox and Orient Europharma completes a phase II trial in Intradialytic hypotension in Taiwan (IV) (NCT01672008)
- 08 Jun 2015 Phase-I/II clinical development is ongoing for septic shock, and phase-II development is ongoing for intradialytic hypotension